2014 Big Pharma China Growth: The Winner Is…
This article was originally published in PharmAsia News
Executive Summary
Despite turbulence in China, multinational drug makers grew on average by 12% in the year, with sales at some increasing by more than 20%. PharmAsia News has combed through pages of earnings releases to identify the winner and winning strategies, as well as the fastest improvers and laggards.